Report Detail

Other Global Total Artificial Heart Market Insights, Forecast to 2025

  • RnM2953517
  • |
  • 13 March, 2019
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Other

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart.
A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

North America is the largest consumption place, with a consumption market share nearly 61% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 39%.
The global Total Artificial Heart market is valued at 24 million US$ in 2018 and will reach 87 million US$ by the end of 2025, growing at a CAGR of 20.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Total Artificial Heart market based on company, product type, end user and key regions.

This report studies the global market size of Total Artificial Heart in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Total Artificial Heart in these regions.
This research report categorizes the global Total Artificial Heart market by top players/brands, region, type and end user. This report also studies the global Total Artificial Heart market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
SynCardia
BiVACOR
CARMAT
ReinHeart TAH GmbH
Cleveland Heart
AbioMed
OregonHeart, Inc

Market size by Product
SynCardia
Others
Market size by End User
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Total Artificial Heart market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Total Artificial Heart market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Total Artificial Heart companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Total Artificial Heart submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Total Artificial Heart are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Total Artificial Heart market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Total Artificial Heart Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Total Artificial Heart Market Size Growth Rate by Product
      • 1.4.2 SynCardia
      • 1.4.3 Others
    • 1.5 Market by End User
      • 1.5.1 Global Total Artificial Heart Market Size Growth Rate by End User
      • 1.5.2 Dilated Cardiomyopathy
      • 1.5.3 Ischemic Cardiomyopathy
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Total Artificial Heart Market Size
      • 2.1.1 Global Total Artificial Heart Revenue 2014-2025
      • 2.1.2 Global Total Artificial Heart Sales 2014-2025
    • 2.2 Total Artificial Heart Growth Rate by Regions
      • 2.2.1 Global Total Artificial Heart Sales by Regions
      • 2.2.2 Global Total Artificial Heart Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Total Artificial Heart Sales by Manufacturers
      • 3.1.1 Total Artificial Heart Sales by Manufacturers
      • 3.1.2 Total Artificial Heart Sales Market Share by Manufacturers
      • 3.1.3 Global Total Artificial Heart Market Concentration Ratio (CR5 and HHI)
    • 3.2 Total Artificial Heart Revenue by Manufacturers
      • 3.2.1 Total Artificial Heart Revenue by Manufacturers (2014-2019)
      • 3.2.2 Total Artificial Heart Revenue Share by Manufacturers (2014-2019)
    • 3.3 Total Artificial Heart Price by Manufacturers
    • 3.4 Total Artificial Heart Manufacturing Base Distribution, Product Types
      • 3.4.1 Total Artificial Heart Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Total Artificial Heart Product Type
      • 3.4.3 Date of International Manufacturers Enter into Total Artificial Heart Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Total Artificial Heart Sales by Product
    • 4.2 Global Total Artificial Heart Revenue by Product
    • 4.3 Total Artificial Heart Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Total Artificial Heart Breakdown Data by End User

    6 North America

    • 6.1 North America Total Artificial Heart by Countries
      • 6.1.1 North America Total Artificial Heart Sales by Countries
      • 6.1.2 North America Total Artificial Heart Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Total Artificial Heart by Product
    • 6.3 North America Total Artificial Heart by End User

    7 Europe

    • 7.1 Europe Total Artificial Heart by Countries
      • 7.1.1 Europe Total Artificial Heart Sales by Countries
      • 7.1.2 Europe Total Artificial Heart Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Total Artificial Heart by Product
    • 7.3 Europe Total Artificial Heart by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Total Artificial Heart by Countries
      • 8.1.1 Asia Pacific Total Artificial Heart Sales by Countries
      • 8.1.2 Asia Pacific Total Artificial Heart Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Total Artificial Heart by Product
    • 8.3 Asia Pacific Total Artificial Heart by End User

    9 Central & South America

    • 9.1 Central & South America Total Artificial Heart by Countries
      • 9.1.1 Central & South America Total Artificial Heart Sales by Countries
      • 9.1.2 Central & South America Total Artificial Heart Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Total Artificial Heart by Product
    • 9.3 Central & South America Total Artificial Heart by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Total Artificial Heart by Countries
      • 10.1.1 Middle East and Africa Total Artificial Heart Sales by Countries
      • 10.1.2 Middle East and Africa Total Artificial Heart Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Total Artificial Heart by Product
    • 10.3 Middle East and Africa Total Artificial Heart by End User

    11 Company Profiles

    • 11.1 SynCardia
      • 11.1.1 SynCardia Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 SynCardia Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 SynCardia Total Artificial Heart Products Offered
      • 11.1.5 SynCardia Recent Development
    • 11.2 BiVACOR
      • 11.2.1 BiVACOR Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 BiVACOR Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 BiVACOR Total Artificial Heart Products Offered
      • 11.2.5 BiVACOR Recent Development
    • 11.3 CARMAT
      • 11.3.1 CARMAT Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 CARMAT Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 CARMAT Total Artificial Heart Products Offered
      • 11.3.5 CARMAT Recent Development
    • 11.4 ReinHeart TAH GmbH
      • 11.4.1 ReinHeart TAH GmbH Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 ReinHeart TAH GmbH Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 ReinHeart TAH GmbH Total Artificial Heart Products Offered
      • 11.4.5 ReinHeart TAH GmbH Recent Development
    • 11.5 Cleveland Heart
      • 11.5.1 Cleveland Heart Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Cleveland Heart Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Cleveland Heart Total Artificial Heart Products Offered
      • 11.5.5 Cleveland Heart Recent Development
    • 11.6 AbioMed
      • 11.6.1 AbioMed Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 AbioMed Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 AbioMed Total Artificial Heart Products Offered
      • 11.6.5 AbioMed Recent Development
    • 11.7 OregonHeart, Inc
      • 11.7.1 OregonHeart, Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 OregonHeart, Inc Total Artificial Heart Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 OregonHeart, Inc Total Artificial Heart Products Offered
      • 11.7.5 OregonHeart, Inc Recent Development

    12 Future Forecast

    • 12.1 Total Artificial Heart Market Forecast by Regions
      • 12.1.1 Global Total Artificial Heart Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Total Artificial Heart Revenue Forecast by Regions 2019-2025
    • 12.2 Total Artificial Heart Market Forecast by Product
      • 12.2.1 Global Total Artificial Heart Sales Forecast by Product 2019-2025
      • 12.2.2 Global Total Artificial Heart Revenue Forecast by Product 2019-2025
    • 12.3 Total Artificial Heart Market Forecast by End User
    • 12.4 North America Total Artificial Heart Forecast
    • 12.5 Europe Total Artificial Heart Forecast
    • 12.6 Asia Pacific Total Artificial Heart Forecast
    • 12.7 Central & South America Total Artificial Heart Forecast
    • 12.8 Middle East and Africa Total Artificial Heart Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Total Artificial Heart Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Total Artificial Heart . Industry analysis & Market Report on Total Artificial Heart is a syndicated market report, published as Global Total Artificial Heart Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Total Artificial Heart market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,900.40
      5,850.60
      7,800.80
      4,552.10
      6,828.15
      9,104.20
      754,306.00
      1,131,459.00
      1,508,612.00
      409,199.00
      613,798.50
      818,398.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report